Common cough syrup ingredient shows promise in treating serious lung disease
EMBL scientists discovered that dextromethorphan, an FDA-approved active ingredient in cough syrups, has potential to treat fibrotic lung disease by containing collagen and other pro-fibrotic molecules capable of forming scars inside the cells.
SCIENCE & TECHNOLOGY2024
science-technology
